OA-13 Increased levels of circulating tumor cells correlate with adverse clinical outcomes and distinct biological features in newly diagnosed patients with multiple myeloma

Article2023

Low Levels of Circulating Tumor Cells Correlate with Favorable Clinical Outcome and Unique Biological Features in Newly Diagnosed Multiple Myeloma Patients

Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Pantelis Rousakis, Evangelos Eleutherakis‐Papaiakovou, Chrysanthi Panteli, Panagiotis Malandrakis, Nikolaos Angelis, Nikolaos Kanellias, Georgia Dimitrakopoulou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Meletios A Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos

Preprint2024

Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma

Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Pantelis Rousakis, Panagiotis Malandrakis, Chrysanthi Panteli, Evangelos Eleutherakis‐Papaiakovou, Nikolaos Angelis, Vasiliki Spiliopoulou, Panagiotis Bakouros, Rodanthi‐Eleni Syrigou, Georgia Dimitrakopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Nikolaos Paschalidis, Maria Gavriatopoulou, Efstathios Kastritis, Meletios A Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos

Article2024

Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma

Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Pantelis Rousakis, Panagiotis Malandrakis, Chrysanthi Panteli, Evangelos Eleutherakis‐Papaiakovou, Nikolaos Angelis, Vasiliki Spiliopoulou, Rodanthi‐Eleni Syrigou, Panagiotis Bakouros, Georgia Dimitrakopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Nikolaos Paschalidis, Maria Gavriatopoulou, Efstathios Kastritis, Meletios A Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos

Article2022

Increased Levels of Circulating Plasma Cells in Patients with Newly Diagnosed Multiple Myeloma Are Independently Associated with Poor Prognosis

Ioannis V. Kostopoulos, Panagiotis Malandrakis, Ioannis Ntanasis‐Stathopoulos, Pantelis Roussakis, Evangelos Eleutherakis Papaiakovou, Chrysanthi Panteli, Nikolaos Angelis, Nikolaos Kanellias, Nikolaos Orologas‐Stavrou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Maria Gavriatopoulou, Efstathios Kastritis, Ourania Tsitsilonis, Meletios A Dimopoulos, Evangelos Terpos

Article2024

OA-20 A New Circulating Tumor Cell-Based Prognostic System To Refine Patient Stratification Status of Newly Diagnosed Multiple Myeloma Patients

Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Pantelis Rousakis, Panagiotis Malandrakis, Chrysanthi Panteli, Nikolaos Tsakirakis, Evangelos Eleftherakis-Papaiakovou, Nikolaos Angelis, Vasiliki Spiliopoulou, Rodaanthi-Eleni Syrigou, Panagiotis Bakouros, Georgia Dimitrakopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Maria Gavriatopoulou, Efstathios Kastritis, Meletios A Dimopoulos, Ourania Tsitsilonis, Evangelos Terpos

Discussion(0)

Related publications

Low Levels of Circulating Tumor Cells Correlate with Favorable Clinical Outcome and Unique Biological Features in Newly Diagnosed Multiple Myeloma Patients

Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma

Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma

Increased Levels of Circulating Plasma Cells in Patients with Newly Diagnosed Multiple Myeloma Are Independently Associated with Poor Prognosis

OA-20 A New Circulating Tumor Cell-Based Prognostic System To Refine Patient Stratification Status of Newly Diagnosed Multiple Myeloma Patients